SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Granules India to set up R&D unit at Pune

12 Dec 2011 Evaluate

Granules India received board of director’s nod for setting up of Research & Development (R&D) unit at Pune (Maharashtra). The company has considered and approved the business at boards meet held on December 12, 2011.

The company is a producer of active pharmaceutical ingredients (API's) and pharmaceutical formulation intermediates (PFIs) with complete vertical integration. They expertise in manufacturing PFIs which are Directly Compressible Granules has helped customers to move to the next level of outsourcing in the pharmaceutical industry.

Granules India Share Price

743.35 7.40 (1.01%)
07-May-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1834.40
Dr. Reddys Lab 1306.80
Cipla 1362.85
Zydus Lifesciences 940.10
Lupin 2459.75
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×